ConductScience.org, home

Paper37293185

Rationale and strategies for the development of safe and effective optimized AAV vectors for human gene therapy.

Srivastava A. Mol Ther Nucleic Acids, 2023. Cited by 48 papers, by iCite.

Cite this record

ConductScience Library. Rationale and strategies for the development of safe and effective optimized AAV vectors for human gene therapy. Papers, record 37293185. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37293185

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rationale and strategies for the development of safe and effective optimized AAV vectors for human gene therapy.
PubMed
Journal
Mol Ther Nucleic Acids
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
48
iCite
Relative citation ratio, by iCite
5.24
iCite
Revised in PubMed
2026-09-06
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Srivastava AArun

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 GM119186NIGMS NIH HHSUnited StatesR01GM119186PubMedNIH RePORTER
R21 AR081018NIAMS NIH HHSUnited StatesR21AR081018PubMedNIH RePORTER

Download CSV of grants

References136

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119603002Generation of novel AAV variants by directed evolution for improved CFTR delivery to human ciliated airway epithelium.Mol Ther2009https://conductscience.org/library/papers/19603002PubMed
229224506AAV5-Factor VIII Gene Transfer in Severe Hemophilia A.N Engl J Med2017https://conductscience.org/library/papers/29224506PubMed
316285001Combinatorial engineering of a gene therapy vector: directed evolution of adeno-associated virus.J Gene Med2006https://conductscience.org/library/papers/16285001PubMed
410841516Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus.J Clin Invest2000https://conductscience.org/library/papers/10841516PubMed
528956530Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6.Elife2017https://conductscience.org/library/papers/28956530PubMed
617369837CD8(+) T-cell responses to adeno-associated virus capsid in humans.Nat Med2007https://conductscience.org/library/papers/17369837PubMed
720736929High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines.Mol Ther2010https://conductscience.org/library/papers/20736929PubMed
814325163ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES.Science1965https://conductscience.org/library/papers/14325163PubMed
918400866In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses.J Virol2008https://conductscience.org/library/papers/18400866PubMed
107623375Rescue and replication signals of the adeno-associated virus 2 genome.J Mol Biol1995https://conductscience.org/library/papers/7623375PubMed
118383071Versatile adeno-associated virus 2-based vectors for constructing recombinant virions.Gene1993https://conductscience.org/library/papers/8383071PubMed
1235857660Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B.N Engl J Med2022https://conductscience.org/library/papers/35857660PubMed
1326949410The Adeno-Associated Virus Genome Packaging Puzzle.J Mol Genet Med2015https://conductscience.org/library/papers/26949410PubMed
1418728640DNA shuffling of adeno-associated virus yields functionally diverse viral progeny.Mol Ther2008https://conductscience.org/library/papers/18728640PubMed
1531914802Adeno-Associated Virus Serotype-Specific Inverted Terminal Repeat Sequence Role in Vector Transgene Expression.Hum Gene Ther2020https://conductscience.org/library/papers/31914802PubMed
1621956692Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors.Gene Ther2012https://conductscience.org/library/papers/21956692PubMed
176095038A human parvovirus, adeno-associated virus, as a eucaryotic vector: transient expression and encapsidation of the procaryotic gene for chloramphenicol acetyltransferase.Mol Cell Biol1984https://conductscience.org/library/papers/6095038PubMed
1819586787AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells.Mol Genet Metab2009https://conductscience.org/library/papers/19586787PubMed
196352411Cloning of infectious adeno-associated virus genomes in bacterial plasmids.Gene1983https://conductscience.org/library/papers/6352411PubMed
209380728Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9380728PubMed

See all 136 referencesDownload CSV of references

Cited by39

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.

PMIDTitleJournalYearIn PapersSource
42930010Advanced Therapies for Diabetic Kidney Disease: A Critical Review of Gene-, RNA-, and Cell-Based Strategies to Address Residual Risk.Diseases2026https://conductscience.org/library/papers/42930010PubMed
42179677Continuous production of recombinant adeno-associated virus in the insect cell/baculovirus expression vector system.Mol Ther Adv2026https://conductscience.org/library/papers/42179677PubMed
42080142Barrier Function of the Extracellular Matrix in AAV Gene Therapy.Cell Mol Bioeng2026https://conductscience.org/library/papers/42080142PubMed
41900881Improvement of Adeno-Associated Virus (AAV)-Based Technologies by Cell-Penetrating Penta-Peptides (CPP5s).Pharmaceutics2026https://conductscience.org/library/papers/41900881PubMed
41744777A Rationally Designed AAV9-DM Capsid with Minimal Liver Tropism.Cells2026https://conductscience.org/library/papers/41744777PubMed
41502088Deaths in gene therapy of Duchenne muscular dystrophy and other diseases: Underlying mechanisms and mitigating strategies.Mol Ther2026https://conductscience.org/library/papers/41502088PubMed
41498205DNA-based delivery of G-CSF as a durable and efficacious approach to treat severe chronic neutropenia.Mol Ther2025https://conductscience.org/library/papers/41498205PubMed
41489395mGem: AAV, from almost a virus to an awesome vector-or is it?mBio2026https://conductscience.org/library/papers/41489395PubMed
41463087Gene Therapy in Crohn's Disease: Current Preclinical Challenges and Future Translational Avenues.Biomedicines2025https://conductscience.org/library/papers/41463087PubMed
41452431Intelligent design of tumor microenvironment-responsive Adeno-associated virus vectors: overcoming delivery barriers and enabling precision therapy.Med Oncol2025https://conductscience.org/library/papers/41452431PubMed
41271662Multiscale red blood cell hitchhiking for targeted deep tissue gene delivery in lungs.Nat Commun2025https://conductscience.org/library/papers/41271662PubMed
41209590Adeno-associated viral vectors encoding anti-P2X7 nanobodies reduce graft-versus-host disease in a humanised mouse model.Clin Transl Immunology2025https://conductscience.org/library/papers/41209590PubMed
41127004A novel gene delivery platform based on a commensal human anellovirus demonstrates transduction in multiple tissue types.Mol Ther Methods Clin Dev2025https://conductscience.org/library/papers/41127004PubMed
41034677Key Challenges and Optimization Practices for Non-clinical Evaluation of AAV based Gene Therapy for Central Nervous System Disease.Pharm Res2025https://conductscience.org/library/papers/41034677PubMed
40943204AAV-Based Gene Therapy: Opportunities, Risks, and Scale-Up Strategies.Int J Mol Sci2025https://conductscience.org/library/papers/40943204PubMed
40935897Dual AAV vectors for efficient delivery of large transgenes.Nat Protoc2026https://conductscience.org/library/papers/40935897PubMed
40868148Gene Therapy of Adrenomyeloneuropathy: Challenges, Target Cells, and Prospectives.Biomedicines2025https://conductscience.org/library/papers/40868148PubMed
40237057Imaged Capillary Isoelectric Focusing (icIEF) Platform for Characterization of Charge Variants of Adeno-Associated Virus (AAV) Capsids and Impact on their Transduction Efficiency.Curr Gene Ther2026https://conductscience.org/library/papers/40237057PubMed
40186350AAV vector development, back to the future.Mol Ther2025https://conductscience.org/library/papers/40186350PubMed
40160975Impact of DNase digestion on titer measurements of engineered adeno-associated virus serotypes.Mol Ther Methods Clin Dev2025https://conductscience.org/library/papers/40160975PubMed

See all 39 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
FKBP42288PubTator's text mininghttps://conductscience.org/library/genes/2288NCBI Gene
KRT2054474PubTator's text mininghttps://conductscience.org/library/genes/54474NCBI Gene
PTK2B2185PubTator's text mininghttps://conductscience.org/library/genes/2185NCBI Gene
TLR954106PubTator's text mininghttps://conductscience.org/library/genes/54106NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37293185

GET https://conductscience.org/api/papers/v1/37293185/references?page=2